Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
- Weight Loss
- Personal Care
- Diet System
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 121792
IPSCIO Record ID: 114672
IPSCIO Record ID: 211879
Licensor grants the right of first refusal to obtain an exclusive license in the territory to make, have made, use, sell, offer for sale, and import product, with the right to grant sublicenses, in respect of all new product development concerning or relating to appetite suppression, meal replacement for weight management, weight loss and/or weight management not covered by patents or know-how and in respect of which Licensor intends to use a Third Party to further develop and/or commercialize such new product, upon terms to be mutually negotiated by the parties in good faith.
Licensor shall grant an Exclusive Period of ninety days following notification of each such new product development to negotiate and agree the terms of an exclusive license.
Satietrol(R) js patented appetite control technology. Satietrol works by stimulating the body's own satiety peptide, cholecystokinin (CCK). Prescription drugs that work by stimulating satiety peptides may be the wave of the future for weight control.
Patent No. 6,207,638 – Nutritional Intervention Composition for Enhancing and Extending Satiety
IPSCIO Record ID: 273411
(a) develop, make, have made, import, use, lease, offer for sale, sell, and distribute Licensed Products;
(b) develop, make, have made, import, use, lease, offer for sale, sell, and distribute Licensed Processes
(c) develop, make, have made, perform, provide, import, use, lease, offer for sale, sell, and distribute Licensed Services; and/or
(d) practice and use the Licensor Intellectual Property rights, other than Licensor Patent rights, and to use the Licensor materials, insofar as such practice and use is required to carry out the activities under subsections (a)-(c) above.
Licensed Product means any product or part thereof containing mirtazapine or setiptiline in any form, (including, without limitation, any and all enantiomers, analogs, derivatives and salts thereof) used in combination with one or more active ingredients.
Licensor Patent Rights (Duke Patents)
Serial No. 60/535,799 – Method of reducing weight gain risk associated with antidepressant therapy.
Serial No. 60/567,896 – Compositions for affecting weight loss.
Serial No. 60/616,393 – Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss.
One of the specified uses under the agreement is development program for obstructive sleep apnea.
IPSCIO Record ID: 138053
BELVIQ refers to each of the formulations of lorcaserin approved for weight management. In Mexico it is marketed under the brand name VENESPRIÂ®.